Predictive BiotechPredictive Technology Group is dedicated to helping women and their clinicians identify the barriers that impact lifelong health through our genetic library, genomic mapping and individualized diagnostics. We are committed to building healthier families through our innovations in bioscience to deliver on personalized medicine.
Predictive Biotech
Regenerative Cell & Tissue Products
Predictive Biotech, Inc., a Salt Lake City, UT life sciences Company formed in 2015, is a leader in human cell and tissue products for use in regenerative medicine. Our research and use of proprietary processing methods have propelled Predictive’s placental-derived and Wharton’s Jelly umbilical cord-derived products to new heights.
Avalon GloboCareAvalon’s subsidiary and joint venture structure contribute to investor flexibility and R&D focus, enabling Avalon to establish our leading role in the fields of immune effector cell therapy (including CAR-T and CAR-NK), exosome-based regenerative therapeutics (our ACTEXTM platform), as well as "liquid biopsy" diagnostics.
Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients’ growth, development, as well as competitiveness in healthcare and CellTech industry markets.
- Advancing and Empowering Innovative, Transformative Immune Effector Cell Therapy
- Exosome Technology
Avalon GloboCare Corp. is a clinical-stage, leading CellTech bio-developer dedicated to
- A premiere healthcare management provider & biotechnology developer
- Dedicated to integrating & managing global healthcare resources
- Empowering high-impact biomedical innovations
- Engaging in bio-venture investment